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ABSTRACT 
Inulin is an extremely adaptable polysaccharides consisting of glucopyranose end-capped (β-1,2) fructose 
repeating units and, as it is, can be classified as an inherently multifunctional polymeric scaffold. It may be 
further functionalized employing mild conditions to give rise desired biological and physicochemical 
properties exploitable for targeted anticancer applications (e.g., active targeting toward specific cytotypes, 
self-assembling behavior, selective cytoxicity and hyperthermia features). In this review, the main chemical 
features and the inulin derivatives applications in the field of targeted anticancer therapy is reported and 
discussed 
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I. INTRODUCTION 
The last forty years have witnessed the 
progress in polymeric materials in the field 
of healthcare. Special attention has been 
directed to the development of new 
nanomedicines for targeted cancer therapy, 
conceived to be accumulated in the tumor 
site in order to release their drug payload 
nearby the site of action thus increasing the 
bioavailability and, as consequence, the 
effectiveness of anticancer drugs [1]. Among 
these, the synthesis of complex functional 
polymers, namely polymers endowed with 
reactive groups whose features (i.e., kind of 
function/s, number, macromolecular 
architecture, etc.) have been arranged, has 
attracted great interest for the development 
of anticancer nanomedicine with selective 
toxicity toward tumor mass instead of 
healthy tissues.  
The aim of this article is to highlight the huge 
potential of a biopolymer named inulin as 
multifunctional vehicle for anticancer drug 
and to provide an updated state-of-the-art on 
chemistry and the rational design of 
innovative drug delivery systems based on 
this peculiar polysaccharide. 
SYNTHETIC FEATURES 
Inulin is a carbohydrate highly available in 
the root of many Arsteracee such as chicory, 
and its hydrolysis by means of inulinase 
leads to a mixture of fructose and glucose 
[2,3]. Recent reliable estimations of the 
molecular weight of inulin have yielded 
values which vary from 5200-200, suggesting 
that its average degree of polymerization 
(DPn) varies from 28-3 as function of the 
natural source. 
From a chemical standpoint it consists of 
glucopyranose end-capped (β-1,2) fructose 
repeating units carrying a high amount of 
hydroxyl functional groups regularly 
arranged in the polymer Chain (Figure 1). 
Apart from the end-chain, inulin exhibits in 
principle three reactive hydroxyl groups per 
repeating unit, two secondary and one 
primary. Notwithstanding the interest in 
obtaining heterodifunctional polymers in 
several biomedical fields [4], nobody has yet 
performed functionalization of this 
polysaccharide exploiting its end-chain 
groups so far. On the opposite, many 
research groups have attempted to realize 
branched tailor-made inulin derivatives as 
polymer therapeutics using its side functions 
[5-13]. The structures of most inulin 
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derivative described so far in which different 
side chains were grafted are reported in 
(Table 1). 
It seems reasonable to assume that only one 
alcoholic group per repeating unit may react 
and, among these, the primary hydroxyl 
functions should be more nucleophilic than 
the other ones. Hence, inulin derivatives 
reported in the literature are essentially 
random copolymers obtained in most cases 
activating the primary hydroxyl groups using 
Bis(4-nitrophenyl) carbonate (BPNPC). 
Noteworthy, using this approach all 
conceivable nucleophiles (e.g., mono- and 
bis- amines, thiols, etc.) are eligible as side 
chains to confer to the main backbone 
desired properties. Another strategy 
encompass the activation of aliphatic 
carboxylic acid employing either a mixture of 
N-hydroxysuccinimide (NHS) and 1-ethyl-3-
(3-(dimethylamino) propyl)-carbodiimide 
hydrochloride.
Figure 1: Structure of inulin and its derivatives recently employed in targeted cancer 
applications. 
Table 1: OH derivatization of inulin backbone with purpose tailored groups. 
No. Functionalization Coupling Agent References 
1  BPNPCa 5 
2  BPNPCa 6 
3  BPNPCa 7 
4 
 
DCCb/NHSSc 8 
5  - 9 
6  EDCd/NHSe 10 
7  - 11 
8  - 
12 
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9  - 12 
10 
 
- 13 
Bis(4-nitrophenyl) carbonate; bN,N’-dicyclohexylcarbodiimide; cN-hydroxysulfosuccinimide; d1- ethyl-
3-(3-(dimethylamino)propyl)-carbodiimide hydrochloride; eN-hydroxysuccinimide. 
 
PHYSICOCHEMICAL FEATURES 
The physicochemical properties of inulin 
strictly depend on its molecular weight and 
distribution. The molecular weight-
dependent behavior of inulin was clearly 
showed by several studies in which the inulin 
conformation in water was related to its DPn. 
It seems that inulin with a DPn smaller than 9 
arranges into helical conformations [14], as 
for inulins sized up to DPn 9 more rigid 
architectures are predominant due to steric 
hindrance [15], thus reflecting in a lower 
water solubility. In the light of this, owing to 
the bigger dimension and the assembling 
abilities, it was realized that high-molecular-
weight-based cancer delivery systems were 
preferred to achieve an effective 
accumulation into the tumor site by means of 
the enhanced permeability retention (EPR) 
effect [16]. 
The amount of reducing sugar, being formed 
as consequence of hydrolysis, is a measure of 
the chemical stability of inulin. Influence of 
many parameters of the chemical stability 
was widely reported in the literature [17]. On 
the whole, inulin results stable under neutral 
and slightly basic conditions, where the free 
sugar in solution revealed only 0.1% 
hydrolysis, whereas it is hydrolyzed under 
acidic conditions especially during heating 
[18]. The acid-dependent hydrolysis of inulin 
may play a crucial rule in its degradation 
inside lysosomes upon cell internalization 
and, hence, should be better studied in future 
works to obtain smart lysosome-triggered 
delivery systems. 
BIOLOGICAL FEATURES 
Inulin is a FDA approved polymer for 
intravenous injection and for the formulation 
of functional foods. Among the relevant 
biological effects of inulin, the most 
interesting is its prebiotic characteristics. In 
particular, colonic fermentation of inulin 
leads to low molecular weight carboxylic 
acids which decrease the cecal pH with 
benefic effects on the tissue perfusion 
accompanied with higher colon motility [19]. 
Besides, inulin represses the growth of 
pathogens (bacteroids, fusobacteria and 
clostridia) [20] for promoting the 
predominance of bifidobacteria in the large 
intestine [21]. Along this line, several authors 
have described a rule of inulin in inhibiting 
colon-rectal pre-neoplastic lesions thus 
suggesting that inulin may suppress colon 
tumorigenesis [19,22]. 
For these reasons it represents a good 
scaffold, in term of biocompatibility and 
synergistic anticancer effect, to prudently 
design novel anticancer delivery systems 
endowed with an exceptional combination of 
prebiotic and pharmacological activities. 
SELF-ASSEMBLED NANOSYSTEMS  
Micelles 
Highly hydrophobized inulin derivatives, 
obtained from the partial substitution of the 
hydroxyl groups of inulin with functional 
hydrophobic chains, were considered for 
anticancer delivery applications. Inulin-D-α-
Tocopherol succinate (INVITE) amphiphilic 
copolymers with different degree of 
derivatization were synthesized to show 
theirs aptitude to form nano-sized micelles at 
low concentration (from 2.4 × 10-3 to 22.3 × 
10-3 mM as function of the amount of INVITE 
chains per macromolecule) able to efficiently 
delivery curcumin inside tumor cells (Figure 
1, (1)) [23]. They are biocompatible, non-
hemolytic and can load suitable amount of 
drug (3% w/w) to be delivered under acidic 
and neutral conditions. The pharmacokinetic 
profile of INVITE-based micelles, obtained on 
Balb/C mice e via intravenous tail vein 
injection at the dose of 50 μg per animal, 
plainly point out that they provide a 
sustained release of curcumin assuring an 
excellent bioavailability up to 6 h from the 
administration. Besides, uptake studied 
carried out on human embryonic kidney 293 
cells clearly showed that they can also 
O Cl
OH
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rapidly enter cells thus releasing their 
payload inside cells. 
In a second investigation [5], an inulin 
conjugate containing ceramide and PEG2000 
was prepared and tested. It was suggested 
that PEGylation would prevent recognition 
by the reticuloendothelial system and 
prolong bloodstream circulation, as ceramide 
in addition to its hydrophobic effect play a 
crucial role in executing antiproliferative 
signaling inside cells (Figures 1 and 2). More 
interesting, these amphiphilic copolymer 
assemblies into micelles once dissolved in a 
solution of doxorubicin in DMSO and placed 
in a dialysis tube against water, with a 
loading capability of 18% on a weight basis. 
Cytotoxicity evaluation on both cancer 
(HCT116) and normal (16 HBE) cell lines 
evidenced a slight preferential cytotoxic 
activity of DOXO-loaded micelles toward 
cancer cells perhaps due to the enhanced 
uptake activity observed on cancer cells. 
Micellar Prodrugs 
Considerable attention has been recently 
focused on a inulin-doxorubicin conjugate 
capable itself of assembling into micelles 
[24]. An efficient conjugation of doxorubicin 
(> 18%w/w) with inulin to give an 
environment-sensitive amphiphile named 
INU-EDA-P,C-Doxo was accomplished via 
amidic bond, employing citraconic acid as a 
pH-sensitive spacer (Figures 1 and 3). The 
authors grafted also pentynoic pendants to 
provide Π-Π structuring in water thus 
yielding to organized assembled micelles of 
about 20 nm at concentration beyond 0.33 
mg mL-1. Cytotoxicity studies carried out on a 
huge array of cancer (HCT 116, MDA-MB 231 
and Sk-Hep-1) and normal (16 HBE, HB-2) 
cell lines point out an evident selective 
cytotoxic effect on cancer cells. Being this 
study performed in vitro this phenomenon 
can be ascribed to biochemical mechanisms 
instead of the EPR effect [16]. Flow 
cytometry measures carried out following 
the fluorescence of the FITC-labelled 
copolymer and the auto-fluorescence of 
doxorubicin suggest a crucial rule of the 
cancer culture microenvironment, that owing 
to its acidic condition provokes the 
hydrolysis of the conjugate at the membrane 
interface bringing about independent 
doxorubicin diffusion throughout the cells. 
On the contrary, in normal cell cultures (pH 
7.4) the unmodified conjugate pass through 
the cell membrane. It was proposed that 
while a partially hydrolyzed conjugate losses 
the self-assembling ability and reverses its 
net charge inside lysosomes (from negative 
to positive), efficiently releasing its payload, 
the unmodified one undergo a contraction of 
volume inside lysosome (the volume here is 
105 lower than cytosol or interstitial liquid) 
implying its assembling into micelles which 
slowly release the drug being highly 
organized (Figure 2). 
There are no doubt that these approach must 
be confirmed in future works, by definitely 
represents a novel frontier to cleverly 
delivery anticancer drugs in order to impart 
selectivity to advanced therapies
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Figure 2: Schematic representation of the mode of action of INU-EDA-P,C-Doxo. pH-sensitive 
citraconylamide spacer (green), doxorubicin (red), inulin backbone (blue).
Nanostructured carbon-nanosheets 
The inulin-doxorubicin conjugate reported 
above (INU-EDA-P,C-Doxo) is not only an 
intrinsically self-assembling anticancer 
prodrug, but is also liable to further 
functionalization via click-chemistry 
reactions. The alkyne moieties available in 
this conjugate were functionalized with a 
discrete PEG-biotin harm, a targeting agent 
widely employed to delivery drugs into 
cancers which overexpress biotin receptors, 
using the bio-orthogonal Huisgen 
cycloaddition [25]. This biotinylated widely 
employed to delivery drugs into cancers 
which overexpress biotin receptors, using 
the bio-orthogonal Huisgen cycloaddition 
[25]. This biotinylated anticancer prodrug 
was combined with reduced graphene oxide 
(RGO) nanosheets, capable of acting as an 
energy-converting device producing heat, in 
order to obtain a Π-Π-staked nanosystem  
simultaneously endowed with synergic 
anticancer effect (i.e., RGO-induced thermal 
ablation and anticancer chemotherapeutic 
effect) and high selectivity (Figure 3). Apart 
from the higher efficacy, the EC50 values on 
MCF-7 cells showed a notwithstanding 
higher potency for the biotinylated system 
instead of the non-biotinylated one (EC50 = 
23 µM vs EC50 > 50 µM). In addition, after 
the treatment of cancer cells with a 810 nm 
laser diode cell viability exponentially 
decreased as consequence of the increased 
temperature, following a dose-response 
curve. The laser treatment also blocked cell 
proliferation of the cells still alive during 24 
h of post-incubation avoiding drug resistance 
mechanisms. This dual effect nanosystem 
appears very active both as a selective 
surgical thermal ablation tool and as 
hyperthermia-triggered drug release and 
sensitization
Figure 3: Formation of Π-Π stacked nanosystem between biotin-containing INU-EDA-P,C-
Doxo and RGO. Thermal ablation of cells, hyperthermia and the selective drug release is 
obtained by irradiating the nanosystem with a 810 nm laser diode.  
SUPERPARAMAGNETIC NANOPARTICLES 
(SPIONs) 
SPIONs 
Superparamgnetic nanoparticles are 
nanocarriers which has proved capable of 
targeting anticancer drugs, avoiding the most 
part of limitations attributable to 
conventional therapeutic tools. Such systems 
allow improved tumor bioavailability 
exploiting a double targeting effect, that is 
enhanced permeability retention effect (EPR) 
(passive) and the magnetic field-triggered 
targeting (active). 
An PEGylated inulin derivative containing 
carboxy-squalenoyl side chains through 
amidic bond was employed as coating agent 
of SPIONs to obtain biocompatible stealth 
doxorubicin delivery systems (Figure 1) 
[26]. These SPIONs were assembled by 
dialyzing against water a suspension of Fe3O4 
in a mixture of the copolymer and 
doxorubicin free base in DMSO. The 
hydrophobic interactions between the 
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squlenoyl tails, doxorubicin and the SPIONs 
surface induced the formation of 
nanoparticels enriched in doxorubicin (11.6 
± 0.5%). Owing to the small dimension (~ 55 
nm, PDI = 0.12) they efficiently enter cells 
and localized inside cytosol. In HCT 116 cell 
culture the inulin-coated SPIONs exhibited a 
significantly higher anticancer activity than 
the free drug especially under the effect of a 
magnetic field place at the bottom of the 
culture (up to three times higher). These 
results indicated that inulin-based SPIONs 
are excellent candidates for the treatment of 
cancers, since they have advantageous 
therapeutic effects, among which local and 
amplified drug uptake and increased 
anticancer activity. 
Magnetoplexes 
Small interfering RNAs (siRNA) have been 
received great attention in the last decade for 
many human disease, comprising cancer. As 
a rule, they need to be carefully targeted 
towards the tumor mass, and then inside 
cancer cells, to efficiently reach the site of 
action (cytosol) avoiding degradation. 
Cationic non-viral delivery systems, such as 
cationic lipids or polyethyleneimine, have 
been already proposed, but they are 
relatively toxic and rapidly localize to lung or 
liver after intravenous administration. Unlike 
many other polycations inulin-based vectors 
bearing either prim- or poly-amines as side 
functions were referred as cytocompatible on 
different cell lines (16HBE, JHH6, HCT-116) 
and capable of easily complexing siRNA [6]. 
More recently highly biocompatible 
magnetoplexes constituted by inulin-
ethylenediamine-coated SPIONs loaded with 
siRNA were obtained by using the layer-by-
layer self-assembly [27] technique [28]. In 
particular, anionic SPIONs of about 20 nm 
were covered by an opposite charged layer of 
inulin-ethylenediamine followed by a last 
shell of anionic siRNA to get to siRNA-coated 
inulin/SPIONs nanostructures of 30 nm 
diameter. This nanosystem stably condensed 
siRNA at vector/siRNA ratio (R) higher than 
10 w/w as a consequence of the net positive 
charge obtained (Z-potential ~ + 25 mV). The 
uptake experiments obtained on normal 
(16HBE) and cancer (JHH6) cell models 
showed that these magnetoplexes can be 
internalized with a remarked R-dependent 
trend (R10 < R20 < R30 = R40), thus 
reflecting on the higher transfection 
efficiency observed at the higher R value. 
Noteworthy, magnetoplexes at R30 
(corresponding to an applied dose of 
siRNA/cell of 63.8 pg) are able to down 
regulate luciferase expression on normal 
cells up to about 70%, while in the presence 
of a magnetic field transfection considerably 
increased up to 95%. On the contrary, an 
identical magnetic field applied on the cancer 
cell culture did not affect luciferase 
expression. This difference should deserve 
further investigations.  
CONCLUSIONS 
Inulin is an FDA approved biopolymer 
endowed with a combination of relevant 
properties making it eligible to design a 
variety of targeted anticancer delivery 
systems. First of all, it contains primary and 
secondary hydroxyl groups homogeneously 
distributed along the main chain which 
confer it a structural versatility enabling to 
finely tune its functionalization with a wide 
array of functional groups such as targeting 
agents, anticancer drugs, environment-
sensitive spacers and long-chain lipophilic 
moieties. The last but not the least, it 
intrinsically displays an anticancer prebiotic 
effect which equips the potential carrier with 
a synergistic anticancer strategy. 
Inulin has been successfully considered for a 
few numbers of applications in targeted 
anticancer therapy. Overall, preliminary 
research data point out that, independently 
from the EPR effect, it somehow provides 
selective in vitro cytotoxicity toward cancer 
cells both as drug loaded self-assembled 
nanocarrier and as self-organized prodrugs. 
Hence, it might be expected that its impact 
will sharply increase in the next years.  
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